Figure 8.
(A) Pharmacokinetics of ‘naked’-, PEGylated-, or PTGG-ylated liposomes after first (day 1) or second (day 7) injection. (B) Biodistribution of the liposomes as assessed by measuring the fluorescence of DiD in the different organs (see Supporting Information, Figure S9). A two-way ANOVA was used to assess statistical significance within treatment groups at different doses (legend) whereas a one-way ANOVA with a Tukey’s means comparison test was used to assess statical significance between groups at 72 h; *P ≤ 0.05; **0.001 ≤ P ≤ 0.01.